~theguardian-world | Bookmarks (3)

Dostarlimab or Jemperli, an immunotherapy used alongside chemotherapy, could extend life expectancyA drug that could improve the quality of life of hundreds of women with womb cancer will be rolled out on the NHS across England from Tuesday.Dostarlimab, also known as Jemperli, is an immunotherapy that works by attracting specific proteins on the surface of cancer cells to help the immune system attack them....

Team at Imperial College London say techniques could be used to flag warning signs during surgeryIt is a high-stakes scenario for any surgeon: a 65-year-old male patient with a high BMI and a heart condition is undergoing emergency surgery for a perforated appendix.An internal bleed has been detected, an anaesthetics monitor is malfunctioning and various bleepers are sounding – before an urgent call comes...

US biotech firm designs cheaper, less invasive multi-cancer screening test it says could be ‘gamechanger’Scientists have developed a simple DNA test that can identify 18 early-stage cancers that experts say could represent a medical “gamechanger”.Cancer accounts for one in every six deaths worldwide, but early detection can significantly improve outcomes. Existing screening tests have drawbacks, including invasiveness, cost and low levels of accuracy for...